                         SEQUENCE LISTING

<110>  THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
 
<120>  AKT AND SHH PATHWAY INHIBITOR COMBINATION THERAPY FOR TREATING 
       BASAL CELL CARCINOMAS

<130>  15003-299PC0

<140>  PCT/US2015/049044
<141>  2015-09-08

<150>  US 62/046,889
<151>  2014-09-05

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  pmTOR4069SOX9BE

<400>  1
tcaatggttt tttgctttgt ttctggagac agggcc                                 36


<210>  2
<211>  31
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  pmTOR9313 SOX9BE

<400>  2
aggctaattc tgaacaatgg tgagttctgt t                                      31


<210>  3
<211>  31
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  pmTOR15126 SOX9BE

<400>  3
ggaaagcaaa gaaacaaagc cactgacata c                                      31


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  mTOR9313IPF

<400>  4
gatggaaagg gatgagcaga                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  mTOR9313IPR

<400>  5
ccaggatcga actctccaac                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  mTOR4069IPF

<400>  6
gccaagagct tggaaaagaa                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide:  mTOR4069IPR

<400>  7
ctcttggggg tgctaggaat                                                   20


